trial

Integrated Coping and Awareness Training

NCTId NCT02400502
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 6 (actual)
Sponsored by University of North Carolina, Chapel Hill
Primary completion 2016-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
6 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2015-03
Primary completion
2016-04
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
I-CAT Therapy

Sponsors

University of North Carolina, Chapel HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

3
Diana O. Perkins, MD, MPHPrincipal Investigator
David L. Penn, PhDPrincipal Investigator
Piper S Meyer-Kalos, PhDPrincipal Investigator

Sites

1 total
Chapel Hill, United States

Facts & assertions

4 sourced
Enrollment
6
Phase
NA
Primary Completion Date
2016-04
Status
COMPLETED
relationships
The graph out of here
drug
I-CAT Therapy
drug
lead_sponsor
University of North Carolina, Chapel Hill
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Diana O. Perkins, MD, MPH
person
David L. Penn, PhD
person
Piper S Meyer-Kalos, PhD
person